WTO Trade Policy Review: Malaysia explains its compulsory license for Hep C drug

On 14 February 2018 and 16 February 2018, the World Trade Organization (WTO) conducted a Trade Policy Review (TPR) of Malaysia. All members of the WTO are subject to review under the Trade Policy Review Mechanism (TPRM). The TPRM takes… Continue Reading

KEI requests that federal government use compulsory licenses on Kaléo held patents for devices used to administer opioid overdose reversal drug

KEI has submitted a request to Mr. James Carroll, Acting Director of the Office of National Drug Control Policy, and to Ms. Kellyanne Conway, Counselor to the President and appointed “opioid czar,” asking that the federal government use its authority… Continue Reading

EC publishes report on protection and enforcement of intellectual property rights in “third countries”

On March 12, 2018, the European Commission issued a press release on a report on the “protection and enforcement of intellectual property rights in third countries”. The report was published on February 21, 2018 and is entitled – “Commission Staff… Continue Reading

Coalition calls on US and Korea Trade Negotiators to prioritize public health over pharma corporations in trade negotiations

FOR IMMEDIATE RELEASE March 12, 2018 kim.treanor@keionline.org (202)-332-2670 A coalition of 16 advocacy organizations in the United States and Korea asked trade negotiators in the U.S. and Korea to reject the demands of the pharmaceutical industry, protect human rights, and… Continue Reading

Statement of Portugal: UN briefing on Promoting Innovation and Access to Health Technologies in the Context of the Agenda 2030

On Tuesday, 6 March 2018, Cristina Pucarinho, the Deputy Permanent Representative of Portugal to the United Nations made the following intervention at a UN briefing on Promoting Innovation and Access to Health Technologies in the Context of the Agenda 2030… Continue Reading